InvestorsHub Logo

Skiluc

05/17/21 6:53 PM

#46 RE: Skiluc #45

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease

https://www.otcmarkets.com/stock/PHRRF/news/PharmaTher-Expands-to-Neuromuscular-Diseases-with-Exclusive-License-Agreement-for-Ketamine-in-the-Treatment-of-Lou-Gehri?id=291989